Literature DB >> 17299449

Functional staging and surgical intervention of the elbow and shoulder joints in a patient with rheumatoid arthritis.

Jörg Goldhahn1, Christoph Kolling, Steffen Gay, Beat R Simmen.   

Abstract

BACKGROUND: A 46-year-old, nonsmoking, nulliparous woman with a 23-year history of rheumatoid arthritis presented with severely destructed right shoulder, right elbow, and right wrist joints, which resulted in a complete loss of working ability. INVESTIGATIONS: Physical examination, X-ray, MRI, ultrasound, functional staging using the Shoulder Pain and Disability Index, the Patient Rated Elbow Evaluation, the Disabilities of the Arm, Shoulder and Hand, and the health-related quality-of-life Short Form 36 questionnaire, determination of the c-reactive protein level, erythrocyte sedimentation rate, Disease Activity Score 28 and the metalloproteinase profile, and histology of removed synovial tissue. DIAGNOSIS: Severe destruction of the right shoulder and elbow (Larsen grade IV) resulting from late-stage seropositive rheumatoid arthritis. MANAGEMENT: Reconstruction of the elbow and ipsilateral shoulder in a two-step procedure: replacement of the elbow joint with a semiconstrained Gschwend-Scheier-Bahler III (GSB III) elbow prosthesis (Zimmer, Inc., Warsaw, IN) followed by replacement of the shoulder with the Promos Modular Shoulder System (Plus Orthopedics AG, Rotkreuz, Switzerland) 1 month later. The patient received 4 weeks of inpatient rehabilitation.

Entities:  

Mesh:

Year:  2007        PMID: 17299449     DOI: 10.1038/ncprheum0407

Source DB:  PubMed          Journal:  Nat Clin Pract Rheumatol        ISSN: 1745-8382


  1 in total

1.  Shoulder tenderness was associated with the inflammatory changes on magnetic resonance imaging in patients with rheumatoid arthritis.

Authors:  Satoshi Shinagawa; Koichi Okamura; Yukio Yonemoto; Hitoshi Shitara; Takahito Suto; Hideo Sakane; Trang Thuy Dam; Tsuyoshi Tajika; Yoshito Tsushima; Kenji Takagishi; Hirotaka Chikuda
Journal:  Sci Rep       Date:  2019-12-20       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.